Genomic profiling of MicroRNAs and proteomics reveals an early molecular alteration associated with tumorigenesis induced by MC-LR in mice

Environmental Science and Technology

Volumn 46, Issue 1, 2012, Pages 34-41

  Zhao, Yanyan ^a   Xie, Ping ^a   Fan, Huihui ^b  

^a INSTITUTE OF HYDROBIOLOGY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC LYMPHOCYTIC LEUKEMIAS; COMPREHENSIVE ANALYSIS; ENVIRONMENTAL HEALTH; GLUTATHIONE METABOLISM; HEPATOCELLULAR CARCINOMA; MAPK SIGNALING; MICROCYSTINS; MICRORNAS; MOLECULAR MECHANISM; MOUSE LIVER; OVARIAN CANCERS; PANCREATIC CANCERS; PITUITARY ADENOMA; PROTEOMICS; TARGET GENES; TRANSCRIPTOMICS; TUMORIGENESIS; TWO-DIMENSIONAL GEL ELECTROPHORESIS (2-DE);

DISEASES; ELECTROPHORESIS; GENES; HEALTH RISKS; LIVING SYSTEMS STUDIES; MAMMALS; MOLECULAR BIOLOGY; PATHOLOGY;

PROTEINS;

GLUTATHIONE; MICROCYSTIN; MICRORNA; MICRORNA 101B; MICRORNA 125B; MICRORNA 148A; MICRORNA 16; MICRORNA 185; MICRORNA 192; MICRORNA 23A; MICRORNA 24; MICRORNA 290; MICRORNA 30C; MICRORNA 45S; MICRORNA 690; MICRORNA 720; MICRORNA 762; MICRORNA B; MITOGEN ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN;

CANCER; CARCINOGEN; ELECTROKINESIS; ENVIRONMENTAL RISK; GEL; GENE EXPRESSION; GENOMICS; METABOLISM; MOLECULAR ANALYSIS; PROTEIN; PROTEOMICS; RNA; RODENT; TUMOR; TWO-DIMENSIONAL MODELING;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE MUTATION; GLUTATHIONE METABOLISM; HYPOPHYSIS ADENOMA; LEUKEMIA; LIVER CELL CARCINOMA; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTOMICS;

ANIMALS; BLOTTING, WESTERN; CELL TRANSFORMATION, NEOPLASTIC; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; LIVER; MICE; MICE, INBRED BALB C; MICROCYSTINS; MICRORNAS; MODELS, GENETIC; NEOPLASMS; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

MUS;

EID: 84855311755     PISSN: 0013936X     EISSN: 15205851     Source Type: Journal    
DOI: 10.1021/es201514h     Document Type: Article

References (50)

1. Chorus, I.; Falconer, I. R.; Salas, H. J.; Bartram, J. Health risks caused by freshwater cyanobacteria in recreational waters J. Toxicol. Environ. Health, Part B 2000, 3, 323-347
2. Dietrich, D.; Hoeger, S. Guidance values for microcystins in water and cyanobacterial supplement products (blue-green algal supplements): a reasonable or misguided approach? Toxicol. Appl. Pharmacol. 2005, 203, 273-289
3. Dahlem, A. M.; Hassan, A. S.; Swanson, S. P.; Carmichael, W. W.; Beasley, V. R. A model system for studying the bioavailability of intestinally administered microcystin-LR, a hepatotoxic peptide from the cyanobacterium Microcystis aeruginosa Pharmacol. Toxicol. 1989, 64, 177-181
4. Ding, W. X.; Shen, H. M.; Ong, C. N. Calpain activation after mitochondrial permeability transition in microcystin-induced cell death in rat hepatocytes Biochem. Biophys. Res. Commun. 2002, 291, 321-331
5. Pouria, S.; de Andrade, A.; Barbosa, J.; Cavalcanti, R. L.; Barreto, V. T.; Ward, C. J.; Preiser, W.; Poon, G. K.; Neild, G. H.; Codd, G. A. Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil Lancet 1998, 352, 21-26
6. Leong, T. Y.; Leong, A. S. Epidemiology and carcinogenesis of hepatocellular carcinoma HPB (Oxford) 2005, 7, 5-15
7. Nishiwaki-Matsushima, R.; Ohta, T.; Nishiwaki, S.; Suganuma, M.; Kohyama, K.; Ishikawa, T.; Carmichael, W. W.; Fujiki, H. Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR J. Cancer Res. Clin. Oncol. 1992, 118, 420-424
8. Ohta, T.; Sueoka, E.; Iida, N.; Komori, A.; Suganuma, M.; Nishiwaki, R.; Tatematsu, M.; Kim, S. J.; Carmichael, W. W.; Nodularin, H. F. A potent inhibitor of protein phosphatases 1 and 2A, is a new environmental carcinogen in male F344 rat liver Cancer Res. 1994, 54, 6402-6406
9. Ito, E.; Kondo, F.; Terao, K.; Harada, K. I. Neoplastic nodular formation in mouse liver induced by repeated intraperitoneal injections of microcystin-LR Toxicon 1997, 35, 1453-1457
10. Yu, S. Z. Drinking water and primary liver cancer. In Primary Liver Cancer; Tang, Z.-Y.; Wu, M.-C.; Xia, S.-S., Eds.; China Academic Publishers: Beijing, 1989; pp 30-37.
11. Ueno, Y.; Nagata, S.; Tsutsumi, T.; Hasegawa, A.; Watanabe, M. F.; Park, H. D.; Chen, G. C.; Chen, G.; Yu, S. Z. Detection ofmicrocystins, a blue-green algal hepatotoxin, in drinking water sampled in Haimen and Fusui, endemic areas of primary liver cancer in China, by highly sensitive immunoassay Carcinogenesis 1996, 17, 1317-1321
12. Fujiki, H.; Suganuma, M. Unique features of the okadaic acid activity class of tumor promoters J Cancer Res. Clin. Oncol. 1999, 125, 150-155
13. Campos, A.; Vasconcelos, V. Molecular mechanisms of microcystins toxicity in animal cells Int. J. Mol. Sci. 2010, 11, 268-287
14. Svircev, Z.; Baltić, V.; Gantar, M.; Juković, M.; Stojanović, D.; Baltić, M. Molecular aspects of microcystins-induced hepatotoxicity and hepatocarcinogenesis J. Environ. Sci. Health, Part C: Environ. Carcinog. Ecotoxicol. Rev. 2010, 28, 39-59
15. Kwak, P. B.; Iwasaki, S.; Tomari, Y. The microRNA pathway and cancer Cancer Sci. 2010, 101, 2309-2315
16. Calin, G. A.; Croce, C. M. MicroRNA signatures in human cancers Nat. Rev. Cancer 2006, 6, 857-866
17. Esquela-Kerscher, A.; Slack, F. J. Oncomirs-microRNAs with a role in cancer Nat. Rev. Cancer 2006, 6, 259-269
18. Zhang, B. H.; Pan, X. P.; Cobb, G. P.; Anderson, T. A. microRNAs as oncogenes and tumor suppressors Dev. Biol. 2007a, 302, 1-12
19. Zhang, B. H.; Pan, X. P. RDX induces aberrant expression of microRNAs in mouse brain and liver Environ. Health Perspect. 2009, 117, 231-240
20. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers Nature 2005, 435, 834-838
21. Joshi, S.; Tiwari, A. K.; Mondal, B.; Sharma, A. Oncoproteomics Clin. Chim. Acta 2011, 412, 217-226
22. Joshi, S.; Tiwari, A. K.; Mondal, B.; Sharma, A. Oncoproteomics Clin. Chim. Acta 2011, 412, 217-226
23. Li, H.; Xie, P.; Li, G.; Hao, L.; Xiong, Q. In vivo study on the effects of microcystin extracts on the expression profiles of proto-oncogenes (c-fos, c-jun and c-myc) in liver, kidney and testis of maleWistar rats injected i.v.with toxins Toxicon 2009, 53, 169-175
24. Livak, K. J.; Schmittgen, T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(T) (-Delta Delta C) method Methods 2001, 25, 402-408
25. Meng, F.; Henson, R.; Wehbe-Janek, H.; Ghoshal, K.; Jacob, S.; Patel, T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer Gastroenterology 2007, 133, 647-658
26. Cole, K. A.; Attiyeh, E. F.; Mosse, Y. P.; Laquaglia, M. J.; Diskin, S. J.; Brodeur, G. M.; Maris, J. M. A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene Mol. Cancer Res. 2008, 6, 735-742
27. Fornari, F.; Milazzo, M.; Chieco, P.; Negrini, M.; Calin, G. A.; Grazi, G. L.; Pollutri, D.; Croce, C. M.; Bolondi, L.; Gramantieri, L. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells Cancer Res. 2010, 70, 5184-5193
28. Tivnan, A.; Tracey, L.; Buckley, P. G.; Alcock, L. C.; Davidoff, A. M.; Stallings, R. L. MicroRNA-34a is a potent tumor suppressor molecule in vivo in neuroblastoma BMC Cancer 2011, 11, 33-43
29. Raver-Shapira, N.; Marciano, E.; Meiri, E.; Spector, Y.; Rosenfeld, N.; Moskovits, N.; Bentwich, Z.; Oren, M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis Mol. Cell 2007, 26, 731-743
30. Takumi, S.; Komatsu, M.; Furukawa, T.; Ikeda, R.; Sumizawa, T.; Akenaga, H.; Maeda, Y.; Aoyama, K.; Arizono, K.; Ando, S.; Takeuchi, T. p53 Plays an important role in cell fate determination after exposure to microcystin-LR Environ. Health Perspect. 2010, 118, 1292-1298
31. Clark, S. P.; Ryan, T. P.; Searfoss, G. H.; Davis, M. A.; Hooser, S. B. Chronic Microcystin Exposure Induces Hepatocyte Proliferation with Increased Expression of Mitotic and Cyclin-associated Genes in P53-deficient Mice Toxicol. Pathol. 2008, 36, 190-203
32. Hermeking, H. The miR-34 family in cancer and apoptosis Cell Death Differ. 2010, 17, 193-199
33. Chen, T.; Wang, Q.; Cui, J.; Yang, W.; Shi, Q.; Hua, Z.; Ji, J.; Shen, P. Induction of apoptosis in mouse liver by microcystin-LR: A combined transcriptomic, proteomic, and simulation strategy Mol. Cell. Proteomics 2005, 4, 958-974
34. Clark, S. P.; Davis, M. A.; Ryan, T. P.; Searfoss, G. H.; Hooser, S. B. Hepatic gene expression changes in mice associated with prolonged sublethal microcystin exposure Toxicol. Pathol. 2007, 35, 594-605
35. Gramantieri, L.; Ferracin, M.; Fornari, F.; Veronese, A.; Sabbioni, S.; Liu, C. G.; Calin, G. A.; Giovannini, C.; Ferrazzi, E.; Grazi, G. L.; Croce, C. M.; Bolondi, L.; Nergini, M. Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma Cancer Res. 2007, 67, 6092-6099
36. Sueoka, E.; Sueoka, N.; Okabe, S.; Kozu, T.; Komori, A.; Ohta, T.; Suganuma, M.; Kim, S. J.; Lim, I. K.; Fujiki, H. Expression of the tumor necrosis factor a gene and early response genes by nodularin, a liver tumor promoter, in primary cultured rat hepatocytes J. Cancer Res. Clin. Oncol. 1997, 123, 413-419
37. Zegura, B.; Zajc, I.; Lah, T. T.; Filipic, M. Patterns of microcystin-LR induced alteration of the expression of genes involved in response to DNA damage and apoptosis Toxicon 2008, 51, 615-623
38. Dowling, V. A.; Sheehan, D. Proteomics as a route to identification of toxicity targets in environmental toxicology Proteomics 2006, 6, 5597-5604
39. Fésüs, L.; Piacentini, M. Transglutaminase 2: an enigmatic enzyme with diverse funcions Trends Biochem. Sci. 2002, 27, 534-539
40. Mehta, K.; Kumar, A.; Kim, H. I. Transglutaminase 2: A multi-tasking protein in the complex circuitry of inflammation and cancer Biochem. Pharmacol. 2010, 80, 1921-1929
41. Sun, Y.; Mi, W.; Cai, J. Q.; Ying, W. T.; Liu, F.; Lu, H. Z.; Qiao, Y. Y.; Jia, W.; Bi, X. Y.; Lu, N.; Liu, S. M.; Qian, X. H.; Zhao, X. H. Quantitative proteomic signature of liver cancer cells: Tissue transglutaminase 2 could be a novel protein candidate of human hepatocellular carcinoma J. Pro. Res. 2008, 7, 3847-3859
42. Boulkroun, S.; Fay, M.; Zennaro, M. C.; Escoubet, B.; Jaisser, F.; Blot-Chabaud, M.; Farman, N.; Courtois-Coutry, N. Characterization of rat NDRG2 (N-Myc downstream regulated gene 2), a novel early mineralocorticoid-specific induced gene J. Biol. Chem. 2002, 277, 31506-31515
43. Liu, N.; Wang, L.; Liu, X.; Yang, Q.; Zhang, J.; Zhang, W.; Wu, Y.; Shen, L.; Zhang, Y.; Yang, A.; Han, H.; Zhang, J.; Yao, L. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines Biochem. Biophys. Res. Commun. 2007, 358, 164-169
44. Lee, D. C.; Kang, Y. K.; Kim, W. H.; Jang, Y. J.; Kim, D. J.; Park, I. Y.; Sohn, B. H.; Sohn, H. A.; Lee, H. G.; Lim, J. S.; Kim, J. W.; Song, E. Y.; Kim, D. M.; Lee, M. N.; Oh, G. T.; Kim, S. J.; Park, K. C.; Yoo, H. S.; Choi, J. Y.; Yeom, Y. I. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis Cancer Res. 2008, 68, 4210-4220
45. Yamaguchi, M. Role of regucalcin in maintaining cell homeostasis and function Int. J. Mol. Med. 2005, 15, 372-389
46. Yamaguchi, M. The transcriptional regulation of regucalcin gene expression Mol. Cell. Biochem. 2011, 346, 147-171
47. Zhang, B. H.; Pan, X. P.; Wang, Q. L.; Cobb, G. P.; Anderson, T. A. Computational identification of microRNAs and their targets Comput. Biol. Chem. 2006, 30, 395-407
48. Hornstein, E.; Shomron, N. Canalization of development by microRNAs Nat. Genet. 2006, 38, S20-S24
49. Takenaka, S. Covalent glutathione conjugation to cyanobacterial hepatotoxin microcystin LR by F344 rat cytosolic andmicrosomal glutathione S-transferases Environ. Toxicol. Pharmacol. 2001, 9, 135-139
50. Schuliga, M.; Chouchane, S.; Snow, E. T. Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic Toxicol. Sci. 2002, 70, 183-192